- Home
- EYPT vs ABL Comparison
EYPT vs ABL Comparison
Compare EYPT & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- ABL
- Stock Information
- Founded
- EYPT 1987
- ABL 2004
- Country
- EYPT United States
- ABL United States
- Employees
- EYPT N/A
- ABL N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- ABL Investment Managers
- Sector
- EYPT Industrials
- ABL Finance
- Exchange
- EYPT Nasdaq
- ABL Nasdaq
- Market Cap
- EYPT 484.4M
- ABL 559.5M
- IPO Year
- EYPT 2005
- ABL N/A
- Fundamental
- Price
- EYPT $10.37
- ABL $5.44
- Analyst Decision
- EYPT Strong Buy
- ABL Strong Buy
- Analyst Count
- EYPT 8
- ABL 4
- Target Price
- EYPT $24.75
- ABL $13.63
- AVG Volume (30 Days)
- EYPT 817.0K
- ABL 1.7M
- Earning Date
- EYPT 08-06-2025
- ABL 08-11-2025
- Dividend Yield
- EYPT N/A
- ABL N/A
- EPS Growth
- EYPT N/A
- ABL N/A
- EPS
- EYPT N/A
- ABL N/A
- Revenue
- EYPT $56,042,000.00
- ABL $134,575,948.00
- Revenue This Year
- EYPT N/A
- ABL $68.84
- Revenue Next Year
- EYPT N/A
- ABL $26.84
- P/E Ratio
- EYPT N/A
- ABL N/A
- Revenue Growth
- EYPT 12.04
- ABL 73.39
- 52 Week Low
- EYPT $3.91
- ABL $5.10
- 52 Week High
- EYPT $13.99
- ABL $11.86
- Technical
- Relative Strength Index (RSI)
- EYPT 72.76
- ABL 28.13
- Support Level
- EYPT $7.94
- ABL $5.21
- Resistance Level
- EYPT $10.77
- ABL $6.11
- Average True Range (ATR)
- EYPT 0.74
- ABL 0.39
- MACD
- EYPT 0.10
- ABL -0.02
- Stochastic Oscillator
- EYPT 85.87
- ABL 18.11
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.